230 related articles for article (PubMed ID: 31071550)
1. The Growth Differentiation Factor-15 (GDF-15) levels are increased in patients with compound heterozygous sickle cell and beta-thalassemia (HbS/β
Larissi K; Politou M; Margeli A; Poziopoulos C; Flevari P; Terpos E; Papassotiriou I; Voskaridou E
Blood Cells Mol Dis; 2019 Jul; 77():137-141. PubMed ID: 31071550
[TBL] [Abstract][Full Text] [Related]
2. Growth differentiation factor-15 in young sickle cell disease patients: relation to hemolysis, iron overload and vascular complications.
Tantawy AA; Adly AA; Ismail EA; Darwish YW; Ali Zedan M
Blood Cells Mol Dis; 2014 Dec; 53(4):189-93. PubMed ID: 25065856
[TBL] [Abstract][Full Text] [Related]
3. Activin-A is elevated in patients with thalassemia major and double heterozygous sickle cell/beta-thalassemia and correlates with markers of hemolysis and bone mineral density.
Voskaridou E; Ntanasis-Stathopoulos I; Christoulas D; Dimopoulou M; Komninaka V; Repa K; Papatheodorou A; Terpos E
Ann Hematol; 2019 Jul; 98(7):1583-1592. PubMed ID: 31041514
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary hypertension in patients with sickle cell/beta thalassemia: incidence and correlation with serum N-terminal pro-brain natriuretic peptide concentrations.
Voskaridou E; Tsetsos G; Tsoutsias A; Spyropoulou E; Christoulas D; Terpos E
Haematologica; 2007 Jun; 92(6):738-43. PubMed ID: 17550845
[TBL] [Abstract][Full Text] [Related]
5. Growth differentiation factor-15 in children and adolescents with thalassemia intermedia: Relation to subclinical atherosclerosis and pulmonary vasculopathy.
Tantawy AA; Adly AA; Ismail EA; Youssef OI; Ali ME
Blood Cells Mol Dis; 2015 Aug; 55(2):144-50. PubMed ID: 26142330
[TBL] [Abstract][Full Text] [Related]
6. Deferasirox effectively decreases iron burden in patients with double heterozygous HbS/β-thalassemia.
Voskaridou E; Plata E; Douskou M; Sioni A; Mpoutou E; Christoulas D; Dimopoulou M; Terpos E
Ann Hematol; 2011 Jan; 90(1):11-5. PubMed ID: 20661572
[TBL] [Abstract][Full Text] [Related]
7. Clinical variability and molecular characterization of Hbs/Gγ (Aγδβ)0-thal and Hbs/HPFH in Indian sickle cell disease patients: AIIMS experience.
Pandey H; Singh K; Ranjan R; Pandey SK; Sharma A; Kishor K; Seth T; Mahapatra M; Saxena R
Hematology; 2019 Dec; 24(1):349-352. PubMed ID: 30777489
[TBL] [Abstract][Full Text] [Related]
8. Levels of growth differentiation factor-15 are high and correlate with clinical severity in transfusion-independent patients with β thalassemia intermedia.
Musallam KM; Taher AT; Duca L; Cesaretti C; Halawi R; Cappellini MD
Blood Cells Mol Dis; 2011 Dec; 47(4):232-4. PubMed ID: 21865063
[TBL] [Abstract][Full Text] [Related]
9. Thrombophilic mutations among Southern Iranian patients with sickle cell disease: high prevalence of factor V Leiden.
Rahimi Z; Vaisi-Raygani A; Nagel RL; Muniz A
J Thromb Thrombolysis; 2008 Jun; 25(3):288-92. PubMed ID: 17619828
[TBL] [Abstract][Full Text] [Related]
10. N-terminal natriuretic peptide and ventilation-perfusion lung scan in sickle cell disease and thalassemia patients with pulmonary hypertension.
Mokhtar GM; Adly AA; El Alfy MS; Tawfik LM; Khairy AT
Hemoglobin; 2010; 34(1):78-94. PubMed ID: 20113292
[TBL] [Abstract][Full Text] [Related]
11. Sickle cell/β0-thalassemia associated with the 1393 bp deletion can be associated with a severe phenotype.
Daniel Y; Hill K; Inusa B; Thein SL; Howard J
Hemoglobin; 2011; 35(4):406-10. PubMed ID: 21797706
[TBL] [Abstract][Full Text] [Related]
12. Erythropoiesis-driven regulation of hepcidin in human red cell disorders is better reflected through concentrations of soluble transferrin receptor rather than growth differentiation factor 15.
Fertrin KY; Lanaro C; Franco-Penteado CF; de Albuquerque DM; de Mello MR; Pallis FR; Bezerra MA; Hatzlhofer BL; Olbina G; Saad ST; da Silva Araújo A; Westerman M; Costa FF
Am J Hematol; 2014 Apr; 89(4):385-90. PubMed ID: 24860871
[TBL] [Abstract][Full Text] [Related]
13. Silent β-thalassemia mutations at -101 (C>T) and -71 (C>T) and their coinheritance with the sickle cell mutation in Bahrain.
Al Moamen NJ; Mahdi F; Salman E; Ahmed T; Abbas R; Al Arrayed S; Sanad H; Ahmed AA
Hemoglobin; 2013; 37(4):369-77. PubMed ID: 23586372
[TBL] [Abstract][Full Text] [Related]
14. Sickle cell/β-thalassemia: Comparison of Sβ
Benites BD; Bastos SO; Baldanzi G; Dos Santos AO; Ramos CD; Costa FF; Gilli SC; Saad ST
Hematology; 2016 Dec; 21(10):623-629. PubMed ID: 27237196
[TBL] [Abstract][Full Text] [Related]
15. Gut leakage enhances sepsis susceptibility in iron-overloaded β-thalassemia mice through macrophage hyperinflammatory responses.
Visitchanakun P; Saisorn W; Wongphoom J; Chatthanathon P; Somboonna N; Svasti S; Fucharoen S; Leelahavanichkul A
Am J Physiol Gastrointest Liver Physiol; 2020 May; 318(5):G966-G979. PubMed ID: 32308038
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor 15 increased in severe aplastic anemia patients.
Shao Y; Wang H; Liu C; Cao Q; Fu R; Wang H; Wang T; Qi W; Shao Z
Hematology; 2017 Oct; 22(9):548-553. PubMed ID: 28385068
[TBL] [Abstract][Full Text] [Related]
17. Chronic inflammatory state in sickle cell anemia patients is associated with HBB(*)S haplotype.
Bandeira IC; Rocha LB; Barbosa MC; Elias DB; Querioz JA; Freitas MV; Gonçalves RP
Cytokine; 2014 Feb; 65(2):217-21. PubMed ID: 24290434
[TBL] [Abstract][Full Text] [Related]
18. Circulating platelet and erythrocyte microparticles in young children and adolescents with sickle cell disease: Relation to cardiovascular complications.
Tantawy AA; Adly AA; Ismail EA; Habeeb NM; Farouk A
Platelets; 2013; 24(8):605-14. PubMed ID: 23249216
[TBL] [Abstract][Full Text] [Related]
19. Genetic Regulation of Redox Balance in β-Thalassemia Trait.
Terán MM; Mónaco ME; Lazarte SS; Haro C; Ledesma Achem E; Asensio NA; Issé BA
Hemoglobin; 2020 Mar; 44(2):122-127. PubMed ID: 32448013
[TBL] [Abstract][Full Text] [Related]
20. Compound Heterozygosity of β-Thalassemia and the Sickle Cell Hemoglobin in Various Populations of Chhattisgarh State, India.
Jha AN; Mishra H; Verma HK; Pandey I; Lakkakula BVKS
Hemoglobin; 2018 Mar; 42(2):84-90. PubMed ID: 30200838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
